Evommune Inc.
EVMN | NYSE
$6.55
-$0.18 (-2.67%)
Nov 2, 2026, 9:32 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
Revenue | 13M | 7M | 5M |
Cost of Revenue | n/a | 1.29M | 1M |
Gross Profit | 13M | 5.71M | 4M |
Operating Income | -81.07M | -70.01M | -37.85M |
Interest Income | 3.32M | 3.24M | 3.86M |
Pretax Income | -68.87M | -66.81M | -34.05M |
Net Income | -68.87M | -66.81M | -34.05M |
Selling & General & Admin | 20.03M | 11.48M | 9.85M |
Research & Development | 74.04M | 64.24M | 32M |
Other Expenses | n/a | n/a | n/a |
Operating Expenses | 94.07M | 75.73M | 41.85M |
Interest Expense | n/a | 34K | 58K |
Selling & Marketing Expenses | n/a | n/a | n/a |
Cost & Expenses | 94.07M | 77.01M | 42.85M |
Income Tax Expense | n/a | n/a | n/a |
Shares Outstanding (Basic) | 31.52M | 30.08M | 30.08M |
Shares Outstanding (Diluted) | 31.52M | 30.08M | 30.08M |
EPS (Basic) | -2.18 | -2.27 | -1.13 |
EPS (Diluted) | -2.18 | -2.27 | -1.13 |
EBITDA | -67.48M | -65.49M | -33M |
EBIT | -68.87M | -66.77M | -34M |
Depreciation & Amortization | 1.39M | 1.29M | 1M |
Add to Watchlist
Select watchlists to add or remove EVMN